Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer

Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer

Since chronic inflammation is associated with ovarian cancer growth and progression, some clinical studies have assessed the association between the pre-treatment neutrophil-to-lymphocyte ratio (NLR) and the prognosis of ovarian cancer. The purpose of this study was to assess the dynamic behavior of...

Full description

Bibliographic Details
Main Authors: Elisabetta Sanna, Luciana Tanca, Cristina Cherchi, Giulia Gramignano, Sara Oppi, Maria Gloria Chiai, Antonio Macciò, Clelia Madeddu
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
ovarian cancer
neoadjuvant chemotherapy
neutrophil-to-lymphocyte ratio
inflammation
c-reactive protein
interleukin-6
Online Access:https://www.mdpi.com/2075-4418/11/7/1298

Internet

https://www.mdpi.com/2075-4418/11/7/1298

Similar Items